PLSE Pulse Biosciences, Inc - Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · pulsebiosciences.com

48.01USD+0.24%Mkt Cap: 3.42B $P/E: —Today

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutane…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap3.42B USD

Enterprise Value3.32B USD

Revenue (TTM)1.19M USD

Gross Profit-189.00K USD

Net Income (TTM)-72.78M USD

Revenue/Share0.02 USD

Last Price48.01 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees116

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-40.94

PEG—

EV/EBITDA-40.20

EV/Revenue2802.96

P/S2883.00

P/B34.09

EPS (TTM)-1.18

EPS (Forward)-1.17

52W Range

12.5677% of range58.90

52W High58.90 USD

52W Low12.56 USD

Profitability

Gross Margin-54.00%

Oper. Margin-5823.04%

EBITDA Margin0.00%

Profit Margin-20794.57%

ROE-90.24%

ROA-76.99%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-54.12M USD

CapEx (TTM)335.00K USD

FCF Margin-2893.27%

FCF Yield-1.00%

Net Debt-94.85M USD

Net Debt/EBITDA1.15

Balance Sheet

Debt/Equity0.09

Current Ratio9.63

Quick Ratio9.27

Book Value/Sh1.41 USD

Cash/Share1.43 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.2 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)54.00 USD

Upside (mean)+12.5%

Target Range35.00 USD – 73.00 USD

35.00+12.5% to mean73.00

# Analysts6

Ownership

Shares Out.71.32M

Float20.65M

Insiders71.05%

Institutions15.40%

Short Interest

Short Ratio5.2d

Short % Float14.72%

Short % Out.4.40%

Shares Short3.14M

Short (prev mo.)2.77M

Technical

SMA 5046.89 (+2.4%)

SMA 20027.73 (+73.2%)

Beta1.63

S&P 52W Chg14.58%

Avg Vol (30d)618.89K

Avg Vol (10d)510.12K

Technical Indicators

RSI (14)46.2

MACD1.4794

MACD Signal2.6607

MACD Hist.-1.1813

BB Upper56.14 USD

BB Middle52.21 USD

BB Lower48.29 USD

BB Width15.04%

ATR (14)3.525 USD

Vol Ratio (20d)0.74x